Burcon NutraScience (BU) Q2 2025 earnings summary

Executive summary

• Announced a transformative shift to direct market reach and control over production, addressing a long-standing supply challenge.

• Strategic alliance formed with a buying group led by a board member to acquire and retrofit a production facility, enabling direct operation and sales of the protein portfolio.

• Achieved first commercial production of canola protein isolate and expanded customer pipeline with over 80 prospects, many in late-stage evaluation.

• Launched PurateinⓇ canola protein into the egg replacement market and completed a process scale-up for a contract research customer.

• Welcomed a new director with extensive food industry experience, supporting go-to-market and commercialization efforts.

Financial highlights

• Cash balance declined from CAD 4.2 million in March to CAD 1 million, with access to an additional CAD 3 million from a loan facility.

• Revenue for the quarter was $40,000, down from $184,000 in the same quarter last year, reflecting a shift from royalty to product and service sales.

• Net loss widened to $2.4 million ($0.02 per share) from $1.4 million ($0.01 per share) year-over-year.

• Gross R&D expenses increased to $1.3 million from $0.9 million, driven by commercialization and patent costs.

• Rights offering launched to raise up to CAD 12 million, supporting operations through to cash flow positive and aligning with facility acquisition.

Outlook and guidance

• Commercial production at the new facility targeted for the first half of 2025, with initial supply contracts expected in Q3 and recurring revenue in Q4.

• Profitability anticipated in calendar 2026, with future margin expansion through licensing and technology sales.

• Management remains focused on ramping production, launching new product lines, and converting prospects into recurring sales.

• Sunflower protein expected to ramp up later than other proteins, with significant adoption projected in late year two into year three.

• Committed to a capital-light business plan and pursuing opportunities to accelerate profitability.